Filagra Oral Jelly Flavored: Compound Profile
Filagra Oral Jelly Flavored 100mg is a sildenafil citrate research formulation manufactured by Centurion Laboratories for in-vitro laboratory studies. This compound belongs to the class of phosphodiesterase type 5 (PDE5) inhibitors and is supplied in convenient oral jelly sachets containing 100mg sildenafil citrate per unit. Researchers at Stroid UK Shop utilise this formulation to investigate the pharmacological properties and mechanism of action of sildenafil citrate in controlled laboratory environments. The flavored jelly formulation offers enhanced convenience for research protocols requiring liquid preparations.
Laboratory Applications
Scientific investigations examine how sildenafil citrate selectively inhibits phosphodiesterase type 5 enzyme activity in cellular assays. Researchers study the compound’s mechanism in modulating cyclic guanosine monophosphate (cGMP) pathways and nitric oxide signaling cascades. The oral jelly formulation allows for precise research protocols investigating bioavailability and pharmacokinetic parameters in controlled studies. Laboratory studies explore the compound’s effects on smooth muscle cell regulation and vascular endothelium responses. Research teams investigating erection drugs and sildenafil citrate compounds frequently incorporate this formulation into their experimental designs. Scientists also examine interactions with selective androgen receptor modulators and peptide compounds in comprehensive research programs.
Product Specifications
| Active Compound | Sildenafil Citrate |
|---|---|
| Concentration | 100mg per sachet |
| Formulation | Oral Jelly |
| Manufacturer | Centurion Laboratories |
| CAS Number | 171599-83-0 |
| Molecular Formula | C₂₈H₃₈N₆O₁₁S |
| Molecular Weight | 666.7 g/mol |
| Storage | Room temperature, dry conditions |
Research Compliance Statement
Filagra Oral Jelly Flavored 100mg is manufactured by Centurion Laboratories exclusively for in-vitro research purposes and laboratory investigation. This product is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must handle this compound in accordance with appropriate laboratory safety protocols and institutional guidelines. All studies involving this sildenafil citrate formulation must be conducted within approved research facilities by qualified scientific personnel. This product is sold strictly for investigational use in controlled laboratory environments only.
